ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 103

$666K Total Retail Price of All Prescriptions

Rank: 17 out of 103

591 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 591 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 591 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,810 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 731 701 1 2
LEVOTHYROXINE SODIUM 692 666 2 1
OMEPRAZOLE 600 572 3 3
LISINOPRIL 521 508 4 5
AMLODIPINE BESYLATE 406 391 5 6
HYDROCHLOROTHIAZIDE 363 363 6 16
FUROSEMIDE 362 332 7 4
ATORVASTATIN CALCIUM 291 280 8 18
WARFARIN SODIUM 278 276 9 7
METOPROLOL TARTRATE 274 269 10 9
TRAMADOL HCL 272 251 11 17
HYDROCODONE-ACETAMINOPHEN 268 218 S3 12 11
POTASSIUM CHLORIDE 255 226 13 10
ATENOLOL 242 235 14 14
CITALOPRAM HBR 202 192 15 15
METFORMIN HCL 196 192 16 13
CRESTOR 179 156 17 27
TAMSULOSIN HCL 178 172 18 23
LOSARTAN POTASSIUM 158 157 19 12
ZOLPIDEM TARTRATE 149 149 20 29
METOPROLOL SUCCINATE 148 144 21 8
DIGOXIN 144 111 22 25
GABAPENTIN 140 112 23 22
DONEPEZIL HCL 139 139 24 28
ALENDRONATE SODIUM 138 134 25 19
CLOPIDOGREL 122 122 26 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 122 26 48
NAMENDA 107 107 28 41
SERTRALINE HCL 101 85 29 21
ESCITALOPRAM OXALATE 101 101 29 73
GEMFIBROZIL 94 77 31 62
DILTIAZEM 24HR CD 92 91 32 61
POLYETHYLENE GLYCOL 3350 90 90 33 31
OXYBUTYNIN CHLORIDE ER 89 89 34 74
PLAVIX 89 89 34 46
AZITHROMYCIN 86 82 36 44
NEXIUM 86 82 36 43
CARVEDILOL 82 82 38 20
JANUVIA 80 80 39 71
ZETIA 79 78 40 66
ALLOPURINOL 77 77 41 26
CEPHALEXIN 71 70 42 72
GLIPIZIDE 71 71 42 65
TRIAMTERENE-HCTZ 71 68 42 38
ISOSORBIDE MONONITRATE ER 67 67 45 37
METFORMIN HCL ER 66 66 46 70
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 47 47
TRAZODONE HCL 63 63 48 52
CYCLOBENZAPRINE HCL 61 36 R 49 83
CARBIDOPA-LEVODOPA 60 60 50 55
SPIRIVA 60 60 50 64
KLOR-CON M20 59 47 52 56
MELOXICAM 56 56 53 49
PREDNISONE 55 52 54 24
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 55 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.